🔎 Trials Near Me

Hjem › Post-COVID-tilstander (lang-COVID) › District of Columbia

Kliniske studier for Post-COVID-tilstander (lang-COVID) i District of Columbia

4 studier for Post-COVID-tilstander (lang-COVID) søker deltakere på steder i District of Columbia.

Byer i District of Columbia

Offisiell studietekst (engelsk)

Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen

  • Research Site, Washington D.C.
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT05624450

A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised

  • Georgetown University Medical Center, Washington D.C.
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT07013474

A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease

  • Georgetown University Medical Center, Washington D.C.
  • Emerson Clinical Research Institute, Washington D.C.
RekruttererFase 3
Alder 12 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT06679140

T Cell Therapy Opposing Novel COVID-19 Infection in Immunocompromised Patients

  • Children's National Hospital, Washington D.C.
RekruttererFase 1
Alder 2 til 80 · Alle kjønn · Oppdatert 12. mar. 2026 · NCT05141058

Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.